Lisata Therapeutics, Inc. (LSTA)

Lisata Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	16.84	16.21	22.59	32.15	24.65	16.51
Short-Term Investments	5.14	15.04	27.94	37.07	70.32	18.06
Cash & Short-Term Investments	21.97	31.25	50.54	69.23	94.97	34.57
Cash Growth	-42.58%	-38.17%	-27.00%	-27.11%	174.69%	37.43%
Accounts Receivable	0.5	0.9	-	-	-	-
Other Receivables	0.7	0.9	-	0.7	-	-
Receivables	1.2	1.8	-	0.7	-	-
Prepaid Expenses	1.71	1.53	3.39	1.95	1.21	0.76
Total Current Assets	24.89	34.58	53.92	71.88	96.18	35.33
Property, Plant & Equipment	0.1	0.21	0.48	0.78	0.79	0.63
Other Intangible Assets	0.16	0.19	0.26	0.33	-	-
Other Long-Term Assets	0.02	0.02	0.02	0.04	0.04	0.04
Total Assets	25.16	35	54.69	73.03	97.01	36
Accounts Payable	0.78	1.28	2.42	2.66	1.93	1.02
Accrued Expenses	3.48	4.19	4	3.55	2.36	2.12
Current Portion of Leases	0.05	0.14	0.17	0.18	0.23	0.37
Total Current Liabilities	4.31	5.61	6.59	6.38	4.52	3.51
Long-Term Leases	-	-	0.14	0.31	0.49	0.25
Other Long-Term Liabilities	0.07	0.07	0.07	0.02	-	-
Total Liabilities	4.39	5.69	6.8	6.71	5.01	3.76
Common Stock	0.01	0.01	0.01	0.01	0	0.02
Additional Paid-In Capital	579.23	578.42	576.97	574.55	546.04	458.75
Retained Earnings	-557.45	-548.07	-528.08	-507.24	-453.02	-425.55
Treasury Stock	-0.71	-0.71	-0.71	-0.71	-0.71	-0.71
Comprehensive Income & Other	-0.05	-0.08	-0.04	-0.03	-0.07	-0.01
Total Common Equity	21.03	29.57	48.15	66.58	92.25	32.5
Minority Interest	-0.25	-0.25	-0.25	-0.25	-0.25	-0.25
Shareholders' Equity	20.78	29.32	47.89	66.32	92	32.24
Total Liabilities & Equity	25.16	35	54.69	73.03	97.01	36
Total Debt	0.05	0.14	0.31	0.49	0.71	0.62
Net Cash (Debt)	21.92	31.11	50.23	68.74	94.26	33.95
Net Cash Growth	-42.37%	-38.07%	-26.93%	-27.07%	177.64%	40.41%
Net Cash Per Share	2.59	3.73	6.22	13.27	25.56	32.98
Filing Date Shares Outstanding	8.76	27.7	8.31	8	4.04	3.97
Total Common Shares Outstanding	8.63	8.41	8.15	7.87	3.99	1.29
Working Capital	20.57	28.97	47.33	65.49	91.66	31.83
Book Value Per Share	2.44	3.52	5.91	8.46	23.14	25.15
Tangible Book Value	20.87	29.38	47.89	66.24	92.25	32.5
Tangible Book Value Per Share	2.42	3.49	5.88	8.42	23.14	25.15
Machinery	0.49	0.59	0.59	0.61	0.34	0.28
Leasehold Improvements	0.07	0.07	0.07	0.1	0.09	0.09

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q